BioSpace News Archive

Healthcare technology company receives NIH funding for low dose MRI exams

Leader on global energy issues and climate change to help carbon-reducing cement and concrete technology expand commercially

Khera will lead regulatory strategy and development services for the company’s sponsor clients across multiple therapeutic indications, clinical development stages and Worldwide’s expanding global clinical trial footprint.

Analyst Confirms PURA Speculative BUY and $0.25 PPS Target

A survey of health plans revealed they used more than 500 provider quality measures with very little overlap between insurers or with the 1,700 measures used by national and regional programs such as NCQA HEDIS®, Medicare Stars, PQRS, MACRA / MIPS, FEP, DSRIP and bundled payments.

Lianluo Smart Limited (“Lianluo Smart” or the “Company”) (Nasdaq: LLIT), a China based professional smart service and products provider announced today that on September 11, 2019, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market LLC

PTC Therapeutics, Inc. (Nasdaq: PTCT) announced today that it has priced its private offering of $250.0 million aggregate principal amount of its convertible senior notes due 2026 (the “Notes”).

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced completion of the last-patient/last-visit in its Phase 3 VANISH 303 study, and that it expects to release top-line data earlier than previously reported. Ibrexafungerp (formerly SCY-078) is the first representative of a novel family of antifungal compounds referred to as triterpenoids

Medecision, an integrated health management solutions company that supports the health and care of more than 50 million consumers nationwide, is excited to announce the formation of its Advisory Board.

Dr. Boyer was initiated as the 74th president of ASSH at their 2019 Annual Meeting in Las Vegas, Nevada.